Nisa Investment Advisors’s Astria Therapeutics ATXS Stock Holding History

Nisa Investment Advisors’s Portfolio ATXS Stock Details ATXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-138	Closed	-$1.81K	–	3046
2025 Q4	$1.81K	Hold	138	–	–	﹤0.01%	2622
2025 Q3	$1K	Hold	138	–	–	﹤0.01%	2746
2025 Q2	$740	Sell	138 -1,749	-93%	-$8.48K	﹤0.01%	2798
2025 Q1	$10.1K	Buy	1,887 +1,855	+5,797%	+$13K	﹤0.01%	2092
2024 Q4	$286	Sell	32 -93	-74%	-$988	﹤0.01%	2904
2024 Q3	$1.38K	Buy	125 +77	+160%	+$856	﹤0.01%	2497
2024 Q2	$437	Buy	48 +30	+167%	+$293	﹤0.01%	2715
2024 Q1	$253	Buy	+18	New	+$224	﹤0.01%	2609

Nisa Investment Advisors's ATXS Position: Q1 2026 in Review

Nisa Investment Advisors sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 138 shares — an estimated $1.81K sold.

Nisa Investment Advisors first reported a position in ATXS in Q1 2024 and held it in 8 quarters. The position peaked at $10.1K in Q1 2025. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.

Nisa Investment Advisors reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
Nisa Investment Advisors sold 138 Astria Therapeutics shares in Q1 2026, an estimated $1.81K.
Nisa Investment Advisors first reported a position in Astria Therapeutics in Q1 2024 and held it in 8 quarters.
Nisa Investment Advisors's Astria Therapeutics position peaked at $10.1K in Q1 2025.
0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.